Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 1-cyclohexyl-2-phenylaminobenzimidazoles as mIDH1 inhibitors for the treatment of tumors

1-cyclohexyl-2-phenylaminobenzimidazoles as mIDH1 inhibitors for the treatment of tumors

US Patent 10137110 · Granted Nov 27, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH2025
Gadolinium chelate compounds for use in magnetic resonance imaging2025
Acyl sulfonamides for treating cancer2025
3-amino-2-[2-(acylamino)pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridi2025
Macrocyclic fluorine substituted indole derivatives2024
Substituted macrocyclic indole derivatives2024
High relaxivity gadolinium chelate compounds for use in magnetic resonance imagi2023
4,5-annulated 1,2,4-triazolones2023
4,5-annulated 1,2,4-triazolones2023
2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH2023
2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH2023
Gadolinium chelate compounds for use in magnetic resonance imaging2022